Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476187 · ClinicalTrials.gov registry record · NA
Benefits of µCor in Ambulatory Decompensated Heart Failure
A NA study, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT03476187 is a NA study that has completed, run by Zoll Medical Corporation. The registered enrollment target is 257 participants.
The verdict
NCT03476187, a NA study, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 days. For all subjects, each scheduled clinic visit will include assessment of cardiac symptoms and any relevant clinically actionable events. The subject will be given a daily diary to track symptoms, unplanned hospital visits, medication changes, and all other heart failure related clinical events. Weekly phone calls to the subject will be given throughout the duration of the study to remind the patient to use the subject diary and to collect and record heart failure related clinical events. Subjects will be contacted six months and one year from initial enrollment to assess the vital status of the subject, any heart failure related clinical events since the end of µCor wear, and any health care utilization since the end of µCor wear.
Interventions
- DEVICE µCor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2018-08-17 |
| Est. Completion | 2024-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476187
The ClinicalTrials.gov registry entry for NCT03476187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which µCor is the first listed.
NCT03476187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03476187 about?
NCT03476187 is a clinical study titled "Benefits of µCor in Ambulatory Decompensated Heart Failure". Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 days. For all subjects, each scheduled clinic visit will include assessment of cardiac symptoms and any relevant clinically actionable events. The subject...
What is the current status of trial NCT03476187?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2018-08-17. Estimated completion is 2024-04-09.
What interventions are being tested in trial NCT03476187?
The interventions under investigation include: µCor (DEVICE).
Who is sponsoring clinical trial NCT03476187?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.